Stay updated on DTG/3TC in HIV-1 Adolescents Clinical Trial

Sign up to get notified when there's something new on the DTG/3TC in HIV-1 Adolescents Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DTG/3TC in HIV-1 Adolescents Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-13T15:59:55.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-06T09:54:56.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.1.
    Difference
    0.7%
    Check dated 2025-05-30T04:50:26.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-23T02:09:38.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T06:16:16.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the introduction of a new study on the efficacy and safety of a fixed-dose combination of Dolutegravir and Lamivudine (DTG/3TC) for HIV-infected adolescents, while extensive details about previous regimens and study phases have been removed.
    Difference
    26%
    Check dated 2025-04-16T20:24:18.000Z thumbnail image

Stay in the know with updates to DTG/3TC in HIV-1 Adolescents Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DTG/3TC in HIV-1 Adolescents Clinical Trial page.